Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daniel

Showing results (431-440 of 445) with videos related to

Pageof 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2020
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153David M Waterhouse, Edward B Garon, Jason Chandler, et al.
Human Mutation|December 23, 2011
Disease-associated mutations in the actin-binding domain of filamin B cause cytoplasmic focal accumulations correlating with disease severityPhilip B Daniel, Tim Morgan, Yasemin Alanay, et al.
The New England Journal of Medicine|September 13, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung CancerYing Cheng, David R Spigel, Byoung Chul Cho, et al.
Regulatory Toxicology and Pharmacology : RTP|May 11, 2026
Retrospective Evaluation of the OECD Adopted In Vitro Skin Irritation/Corrosion Tests for Agrochemical FormulationsAmber B Daniel, Andreia Oliveira Latorre, Arthur Grivel, et al.
American Journal of Perinatology|May 2, 2025
Outcomes of Mothers and Infants Affected by COVID-19Katherine B Daniel, Stefany Olague, Helen Boyle, et al.
American Journal of Medical Genetics. Part A|May 13, 2017
Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotypeEmma M Wade, Zandra A Jenkins, Philip B Daniel, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
American Journal of Human Genetics|July 19, 2016
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal DysplasiaEmma M Wade, Philip B Daniel, Zandra A Jenkins, et al.
American Journal of Human Genetics|December 7, 2015
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous DysplasiaMary J Gray, Peter Kannu, Swarkar Sharma, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 7, 2015
A multicenter study of preventable contact burns from glass fronted gas fireplacesLucy Wibbenmeyer, Michael A Gittelman, Karen Kluesner, et al.
Pageof 45

Showing results (431-440 of 445) with videos related to

Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2020
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153David M Waterhouse, Edward B Garon, Jason Chandler, et al.
Human Mutation|December 23, 2011
Disease-associated mutations in the actin-binding domain of filamin B cause cytoplasmic focal accumulations correlating with disease severityPhilip B Daniel, Tim Morgan, Yasemin Alanay, et al.
The New England Journal of Medicine|September 13, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung CancerYing Cheng, David R Spigel, Byoung Chul Cho, et al.
Regulatory Toxicology and Pharmacology : RTP|May 11, 2026
Retrospective Evaluation of the OECD Adopted In Vitro Skin Irritation/Corrosion Tests for Agrochemical FormulationsAmber B Daniel, Andreia Oliveira Latorre, Arthur Grivel, et al.
American Journal of Perinatology|May 2, 2025
Outcomes of Mothers and Infants Affected by COVID-19Katherine B Daniel, Stefany Olague, Helen Boyle, et al.
American Journal of Medical Genetics. Part A|May 13, 2017
Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotypeEmma M Wade, Zandra A Jenkins, Philip B Daniel, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
American Journal of Human Genetics|July 19, 2016
Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal DysplasiaEmma M Wade, Philip B Daniel, Zandra A Jenkins, et al.
American Journal of Human Genetics|December 7, 2015
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous DysplasiaMary J Gray, Peter Kannu, Swarkar Sharma, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|January 7, 2015
A multicenter study of preventable contact burns from glass fronted gas fireplacesLucy Wibbenmeyer, Michael A Gittelman, Karen Kluesner, et al.
Pageof 45